Sinil Pharmaceutical Co., Ltd.

₩6,150As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:012790Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (1.30%)
Div yield 3.09%
ROE 4.24%
Pharmaceutical Preparations
Beta (5Y) 0.44
PE TTM 11.08
TSR TTM 7.87%
Mkt cap ₩69.96B
ROIC 4.65%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,910
12.36%
(40.92%)
Sell 6|2|4|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
70.93
69.17
71.42
72.84
4.73%
0.23%
(2.17%)
1.36%
Revenue₩B
8.116
8.181
8.624
8.866
15.31%
16.54%
18.72%
15.30%
Peers (US$51.58M)
Cap (US$)
PE
46.94M
—
Capital
TTM
5Y
10Y
Leveragex
9.049
0.611
0.557
EBIT/Intx
1.061
0.508
0.501
Own earn%
14.26
21.47
(2.37)
Sh yield%
45.58
30.30
25.66
Owners
Insiders/Inst%
2.05
84.63
Short interest%
3.01
SBC / revenue%
4.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
3